Cytarabine (liposomal) 50mg/5ml suspension for injection vials
in short Cytarabine (liposomal) 50mg/5ml inj vials
previously Cytarabine 50mg/5ml suspension for injection vials
- SNOMED code
7591711000001106- Named
- Active compound
- Cytarabine (liposomal)
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- ✅ Yes
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 5 ml, vial
- Ingredients
- Cytarabine (liposomal)
— 10 mg
/ 1 ml
based on ingredient substance
- Form & Route
- suspensioninjection.intrathecal
Suspension for injection, Intrathecal - Controlled drug
- No Controlled Drug Status
Products
DepoCyte 50mg/5ml suspension for injection vials (Napp Pharmaceuticals Ltd)
previously DepoCyte 50mg/5ml intrathecal suspension for injection vials
DepoCyte 50mg/5ml suspension for injection vials
- SNOMED code
7591911000001108- Named
- Supplier
- Napp Pharmaceuticals Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- Not available
- Licensed route
- Intrathecal
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
DepoCyte 50mg/5ml suspension for injection vials (Napp Pharmaceuticals Ltd) 1 vial7592011000001101 ref. pack |
Discontinued
Legal category: POM | No Price Available previously: £1,223 | • Personally Administered • Hospital |
| — |
Reference packs
Cytarabine (liposomal) 50mg/5ml suspension for injection vials 1 vial
- SNOMED code
7591811000001103- Quantity and unit
- 1 vial
- Packs